Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 780,940 | 661,377 | 414,594 | 345,104 | 535,865 |
| Marketable Securities | 346,639 | 241,314 | 246,425 | 368,670 | 313,490 |
| Receivables | 324,569 | 317,353 | 282,519 | 284,912 | 276,441 |
| Inventories | 186,220 | 169,102 | 155,119 | 147,024 | 191,022 |
| Income taxes - deferred | N/A | N/A | 44,966 | 55,732 | 33,730 |
| Other current assets | 302,973 | 323,421 | 241,534 | 248,298 | 245,133 |
| TOTAL | $1,941,341 | $1,712,567 | $1,385,157 | $1,449,740 | $1,595,681 |
| Non-Current Assets | |||||
| PPE Net | 1,291,041 | 1,280,385 | 1,246,116 | 1,227,296 | 1,191,968 |
| Investments And Advances | 1,653,363 | 1,657,858 | 1,605,685 | 1,650,486 | 1,701,309 |
| Intangibles | 3,823,835 | 3,901,998 | 3,949,600 | 4,012,640 | 4,035,268 |
| TOTAL | $6,768,239 | $6,840,241 | $6,801,401 | $6,890,422 | $6,928,545 |
| Total Assets | $8,709,580 | $8,552,808 | $8,186,558 | $8,340,162 | $8,524,226 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 102,183 | 100,457 | 62,822 | 62,280 | 58,119 |
| Accrued Expenses | 312,195 | 336,869 | 285,730 | 252,693 | 235,237 |
| TOTAL | $500,448 | $582,855 | $495,010 | $499,982 | $520,797 |
| Non-Current Liabilities | |||||
| Long Term Debt | 52,043 | 96,694 | 45,074 | 44,526 | 43,978 |
| Deferred Revenues | N/A | N/A | 6,730 | 19,415 | 19,226 |
| aiOther Non-Current Liabilities | 195,337 | 79,836 | 98,167 | 95,668 | 80,354 |
| TOTAL | $861,966 | $820,175 | $796,674 | $831,589 | $860,587 |
| Total Liabilities | $1,362,414 | $1,403,030 | $1,291,684 | $1,331,571 | $1,381,384 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 342,162 | 342,437 | 337,127 | 343,594 | 343,862 |
| Common Shares | 173 | 173 | 173 | 173 | 173 |
| Retained earnings | -821,215 | -860,827 | -954,991 | -1,104,681 | -928,178 |
| Other shareholders' equity | 31,464 | 22,200 | -18,194 | -22,674 | 4,326 |
| TOTAL | $7,347,166 | $7,149,778 | $6,894,874 | $7,008,591 | $7,142,842 |
| Total Liabilities And Equity | $8,709,580 | $8,552,808 | $8,186,558 | $8,340,162 | $8,524,226 |